CNSAC MedShop GmbH appears in FDA 510(k) records as the applicant for K260949, Disposable Belts for Polysomnography (CNSAC), received on 23 March 2026 and decided on 24 September 2026 as Substantially Equivalent. The filing lists product code MNR, regulation number 868.2375, device class 2 and the Anesthesiology advisory committee, with a Traditional clearance type and a summary statement. The FDA record gives a Theilheim, Germany address for the applicant; that filing address is not treated here as a verified headquarters. The manufacturer’s own published pages describe a German medical technology company focused on disposable products for sleep diagnostics, oxygen therapy, neurophysiology and cardiology, and list CE/MDR, FDA, TGA and PMDA approvals among its market authorizations. [1][2][3][8]

The documented 510(k) filing

K260949 covers Disposable Belts for Polysomnography (CNSAC). The FDA record identifies the device as a ventilatory effort recorder in class 2 under 21 CFR 868.2375, product code MNR, reviewed by the Anesthesiology panel. The decision code is SESE, described as Substantially Equivalent, dated 24 September 2026, with a Traditional clearance type, no third-party review and a summary document. The applicant contact named in the record is Arash Kianian. [1][2]

The filing is the only linked record in the portfolio snapshot retrieved on 20 November 2026, which shows one 510(k) entry and one SESE decision. That count describes the retrieved filings at that date, not the company’s total portfolio, sales or safety performance. [1]

Product scope as published by the manufacturer

CNSAC MedShop’s published product pages describe breathing sensors and belts for polysomnography, including sensors for respiration pressure and flow, position, snoring and SpO2, positioned for addition to existing PSG or diagnostic systems. The site also references reusable EEG caps and adhesive electrodes within its product navigation. These are the manufacturer’s own descriptions of its catalogue. [4][7]

The company describes itself as developing single-use and reusable medical devices for sleep diagnostics, neurophysiology, cardiology and oxygen therapy, and states that its products are used worldwide. It also states that its products support the diagnosis and care of more than 2 million patients each year. These figures are the manufacturer’s published claims, not independently verified clinical outcomes. [3][5][7][8]

Quality certification and market approvals

The manufacturer’s certificates page states that its quality management is organized according to ISO 13485 and explains what that standard requires of medical device manufacturers. Site footers describe the company as TÜV-tested and ISO 13485 certified. The about page lists CE/MDR (Europe), FDA (USA), TGA (Australia) and PMDA (Japan) among the approvals for its products. [3][6][8]

The FDA clearance for K260949 is consistent with the manufacturer’s statement of FDA approval for its products, though the 510(k) record covers only the named polysomnography belts. No parent company, ownership structure or verified brand hierarchy appears in the reviewed records; the FDA applicant name and the manufacturer name are the same legal entity. [1][3]

What the records do not establish

The reviewed records do not document manufacturing sites, distribution partners, customer names, pricing or commercial availability of the cleared belts. The Theilheim address appears in the FDA filing and in the manufacturer’s contact listings, but no source reviewed here confirms a corporate headquarters designation. Clinical performance of the belts is not described beyond the substantial-equivalence decision. [1][2][8]